SectorLife Science Tools and Services
Established Date--
Listing Date29/11/2018
ExchangeAmerican Stock Exchange
Full-time Employees16
Fiscal Year Ends31/12
Security TypeCommon stock
Office address601 Genome Way
Suite 2001
Huntsville
Alabama 35806
Business
IntroductionSerina Therapeutics, Inc., was incorporated in Delaware in January 2017. The company is a clinical-stage biotechnology company that is developing a series of wholly-owned drug candidates for the treatment of neurological diseases and other indications. The company's POZ drug delivery technology is designed to enable modifications of certain existing drugs and novel drug candidates, with the potential to improve the combined efficacy and safety of multiple drugs including small molecules, RNA-based therapies and antibody-based drug conjugates.
